These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17553807)

  • 1. Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B.
    Påhlman LI; Marx PF; Mörgelin M; Lukomski S; Meijers JC; Herwald H
    J Biol Chem; 2007 Aug; 282(34):24873-81. PubMed ID: 17553807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B.
    Valls Serón M; Plug T; Marquart JA; Marx PF; Herwald H; de Groot PG; Meijers JC
    Thromb Haemost; 2011 Oct; 106(4):609-16. PubMed ID: 21800008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor.
    Plug T; Kramer G; Meijers JC
    J Thromb Haemost; 2014 Oct; 12(10):1717-25. PubMed ID: 25066897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Meijers JC
    J Thromb Haemost; 2003 Jul; 1(7):1566-74. PubMed ID: 12871292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-activatable fibrinolysis inhibitor.
    Marx PF
    Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor.
    Marx PF; Havik SR; Marquart JA; Bouma BN; Meijers JC
    J Biol Chem; 2004 Feb; 279(8):6620-8. PubMed ID: 14660622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
    J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
    Antovic JP; Schulman S; An SS; Greenfield RS; Blombäck M
    Scand J Clin Lab Invest; 2004; 64(8):745-51. PubMed ID: 15719893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificity.
    Zhao L; Buckman B; Seto M; Morser J; Nagashima M
    J Biol Chem; 2003 Aug; 278(34):32359-66. PubMed ID: 12799375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Marx PF; Mosnier LO; Meijers JC
    Thromb Res; 2001 Mar; 101(5):329-54. PubMed ID: 11297751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.
    Sillen M; Declerck PJ
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system.
    Bengtson SH; Sandén C; Mörgelin M; Marx PF; Olin AI; Leeb-Lundberg LM; Meijers JC; Herwald H
    J Innate Immun; 2009; 1(1):18-28. PubMed ID: 20375563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
    Bouma BN; Meijers JC
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.
    te Velde EA; Wagenaar GT; Reijerkerk A; Roose-Girma M; Borel Rinkes IH; Voest EE; Bouma BN; Gebbink MF; Meijers JC
    J Thromb Haemost; 2003 Oct; 1(10):2087-96. PubMed ID: 14521589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules.
    Plug T; Meijers JC
    Thromb Res; 2016 Oct; 146():7-14. PubMed ID: 27564657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.